chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever 102.5; Chills; Felt like really groggy, drowsy, was really sleepy; Arm  swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm  swelling), SOMNOLENCE (Felt like really groggy, drowsy, was really sleepy), PYREXIA (Fever 102.5) and CHILLS (Chills) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm  swelling). On 06-Feb-2021, the patient experienced SOMNOLENCE (Felt like really groggy, drowsy, was really sleepy). On 07-Feb-2021, the patient experienced PYREXIA (Fever 102.5) and CHILLS (Chills). At the time of the report, PERIPHERAL SWELLING (Arm  swelling), SOMNOLENCE (Felt like really groggy, drowsy, was really sleepy), PYREXIA (Fever 102.5) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Body temperature: 102.5 (High) 102.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Received second dose one week early.  Received at 21 days rather than 28.
Patient (DOB 5/6/2019) was present in the clinic on 7/5/2022 for his 1st dose of Pfizer (6 months - 4yrs formulation, lot number FT9142). RN, the vaccinator, coached the Guardian on how to position the child. The child was positioned to sit across guardian's lap and have his left thigh exposed to get the injection in the left vastus lateralis. Guardian was holding child's arms and leg, but the child managed to slip out of Guardians hold and gripped the top of the needle as it began piercing his skin. The needle bent and removed from the skin with the dose squirting into the air. RN was able to visually see that none of the dose enter the site. Guardian was able to state that they also felt the dose squirt onto the arms. RN was able to assess the site for any scratching or bruising as well assessed for any bleeding. Charge nurse, RN notified the site supervisor MSN RN. The Supervisor was able to educate guardian on the need for repeating dose on different site (right vastus lateralis) per our protocol, since less than half or rather none of the dose had entered the site. Guardian was educated on watching the child for any bruising and that the child can be given children's Tylenol for comfort. Guardian expressed understanding and consented to re-administration of dose in opposite site. Client was able to successfully receive dose.
Information has been received from a physician's assistant concerning a 19 year old female who on 23-MAY-2007 was mistakenly vaccinated with a dose of Zostavax instead of human papillomavirus vaccine. It was human error no product confusion. No symptoms or problems noted. No product quality complaint. No further information is available.
As per patient "Noticed an itchy rash on the trunk of my body. Got worse overnight and increased to lower stomach & back."
States that a couple of days after she got her first MMR vaccine on 3/1 she started to have pain, aching and swelling. States it was mild at first and then flared up and was more severe, a couple of days before the 2nd vaccine it was much better and her hands were better. After the  2nd MMR vaccine on 4/5/16 she has had pain and swelling in her hands and wrists every since. States she only has pain in the wrists and hands. She states that she is having pain of 7/10 in both hands and both wrists, feels like they are tight and feels like rubber bands are being pulled and every one of the joints ache. Can't put rings on. States it is hard to make a fist since hands are swollen. States she has been taking Ibuprofen 400-600 mg PO every day one dose and has been using ice to hands every night. The ice helps the pain some for a little while. States nothing makes the pain worse. Will be sending to a physician for follow up and possible treatment.
Patient experienced sweats, fevers, and extreme weakness with difficulty ambulating the afternoon after second COVID vaccine. Patient was  admitted to the hospital overnight for observation and was given tylenol to help with fevers, was discharged the following day.
Post injection headache; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Post injection headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Left deltoid red, painful, fever, Treatment Bactrim DS, Darvocet, Advil.
Puffy on the left side of face from left eye to lip; Tingly on the left side of face from the left eye down to lip; Hard to talk; Face felt heavy; tingly numbness, when she pokes the left side of her face; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, lot Number: EN6207; Expiration Date: 31Jul2021), via an unspecified route of administration in Arm Left on 19Mar2021 09:15 (age at vaccination 50 years) as dose number unknown, single for COVID-19 immunisation. The patient's medical history included psoriasis. Patient stated she was diagnosed in Sep2020 but has had for a while. Patient stated she received a Flu shot a while back in Dec2020 but does not have any further information to provide. There was no family medical history relevant to AE. Concomitant medications included risankizumab rzaa (Skyrizi) taken for psoriasis from Nov2020 to an unspecified stop date. Skyrizi was received in Nov2020, Dec2020, and Mar2021. Patient was taking COVID Vaccine because of Covid prevention. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There was no additional vaccines administered on same date of the Pfizer suspect. AE did not require a visit to emergency room or physician office. There was no AE following prior vaccinations. There was no prior vaccinations within 4 weeks. On 19Mar2021, patient just got the Pfizer Covid Vaccine around 9:15am this morning, about an hour ago the left side of her face started to get puffy, she stated it's not really big, it was a little tingly like when you go to a dentist and had that gas and get home and itches and then she stated she's trying to get that feeling back. Patient clarifies she was puffy on the left side of her face from the left eye down to her lip. It had not swollen up anymore it was just about the same. Patient clarifies she can tell she was better since her talking was better, it was like she was really having to move her mouth since it was heavy. She feels like the swelling has gone down a lot. When she says tingly numbness, when she pokes the left side of her face, she cannot really feel her fingernail but on the other side she can feel it. It's not constant but she was aware of it. Patient did not receive the treatment for events. There were no relevant tests. The outcome of events was recovering.  No follow-up attempts are possible. No further information was expected.
Pt vaxed @ evening clinic, ate dinner & put to bed; 11PM awoke w/fever, mom gave APAP & pt cried all noc & finally fell asleep around 8AM this AM; mom had given APAP & used cold compresses on legs, but pt wouldn't let anything touch leg;
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 30-OCT-2014, the patient was vaccinated with PNEUMOVAX 23 lot # J009827, expiration date 10-AUG-2014, 0.5 ml, intramuscular. Secondary and concomitant therapies were not reported. Pharmacist reported that an expired dose of PNEUMOVAX 23 was inadvertently administered to a patient on 30-OCT-2014. Dose was supported. No adverse experience reported. Additional information has been requested.
Upon review of this account, this patient was supposed to be administered the 2nd Bexsero/MenQuadfi dose since the 1st dose of both vaccines were administered elsewhere on 8/3/23. This patient was administered Trumenba  in error instead of Bexsero dose #2 as prescribed. The MD and the patient will be notified immediately.
Pt received vaccine on 7/7/12. Pt said she covered injection site until 7/9/12 and that her injection site and swelling. Pt came in to px and said lump has increased slightly and wanted to take something because she very itchy.
Patient had a fever of 101 status post vaccine with body aches, rash to the left chest, sinus congestion and post-nasal drip. Symptoms started about 3 days after vaccine administration. Patient is currently inpatient
Site: Pain at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: patient had no reaction at injection site, but would not let me bypass. patient had rash on back of both legs following injection, still present. gave benedryl for second dose on 5/23/21 to see if it helps-Mild
rapid heartbeat; mild hypertension; Difficulty breathing; Swelling of your face and throat; Swelling of your face and throat; A bad rash all over your body; Dizziness and weakness; Dizziness and weakness; This is a spontaneous report from a contactable consumer (Patient). A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 29Apr2021 as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Reportedly, she received the first dose of the Pfizer Covid vaccine on 29 Apr 2021. 4 days after taking the vaccine she began to experience a rapid heartbeat that continues until now. Caller states that she does have mild hypertension, and that she does have an appointment setup with her HCP. On an unspecified date, the patient experienced rapid heartbeat, mild hypertension, difficulty breathing, swelling of your face and throat, a bad rash all over your body, dizziness and weakness. Outcome of the events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
p/vax pt devel several lesions on lower back;pt sought unspecified medical attention;
This is a 74y.o. male with a medical history of hypertension and anxiety on Ativan who presented to the hospital secondary to increased weakness. Patient had difficulty walking when he woke up this morning. He was accompanied by his son who states that the patient also had some slurred speech and left arm and left leg weakness. Patient admits to tobacco dependence at half a pack per day. He states that he sometimes takes an Ativan for anxiety but otherwise denies any history of chronic medical conditions or any medication use. He denies any symptoms at this time.
Swollen Lower Lip with numbness around edges of lip - Patient has never had lip filler injections. Rash of red raised bumps throughout chest, stomach, and back that itch. General itchiness throughout body. Patient tried treating with Benadryl, but that did not help.  Dermatologist prescribed topical steroid cream. If that does not work, doctor will prescribe oral steroid or injection.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age and gender. On 15-SEP-2014 the patient was vaccinated with a dose of VAQTA (dose, route, lot # and expiration date were not reported) that had been improperly stored. No adverse effects were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Mother reported today at another child's office visit that pt experienced swelling and a hard lump, tender to touch, redness, & heat to touch at injection site and painful walking x 3 days after immunization. Ibuprofen and cold packs & rest treated symptoms.
This spontaneous report as received from a certified medical assistant refers to an 11 year old female patient. No information regarding the patient's medical history and concurrent conditions was reported. On 20-APR-2016 at 16:40, the patient was vaccinated at the private doctor's office/hospital with the first dose of GARDASIL 9 injection, lot # L044475, expiration date: 12-MAY-2017, intramuscularly in the right arm (dose was not provided). There were no concomitant medications reported. It was stated that the vaccine was purchased with public funds. The certified medical assistant also reported that the vaccine underwent a temperature excursion of 34 degrees Fahrenheit for a total time of 65 hours. No previous temperature excursion was reported. The call was not because of a data logger. No adverse events, signs or symptoms were reported. No product quality complaint (PQC) was involved. The patient had no illness at the time of vaccination. This is one of several reports received from the same reporter. Additional information is not expected as all required correspondence has been received.
Beginning upon waking up on 7/14/22, left arm (upper arm around tricep area) was swollen and red. No pain. Swelling started to go down 7/16/22 and resolved 7/20/22. As swelling went down, it spread to elbow area of upper arm.
Dizziness  Narrative: c/o dizziness. No LOC. 133/74, 76, 18, 99% O2sat. head to knees and water given to drink. Escorted to her unit for family to pick up. stable
I developed shingles 2 days after receiving a flu shot. It seems many others have too.
I received a Flu shot at store using my Healthcare Card. The Pharmacist gave me the shot at a bad angle and too high on the shoulder. The next day I could barely use my left arm at all. I waited 2 weeks to see if it got better and it was getting worse. I had limited rotation of my Left arm, pain when lifting my arm above the shoulder, heavy ache in the bones and muscles at the injection site. I went to my Primary Care center at the Hospital and they thought it was just fluid on the shoulder and did an Ultrasound. They found nothing wrong. They did not do other tests. But my left arm still hurts when I move it and cracks. I feel it was a Ligament Tear from the injection and it takes 4-8 weeks to heal Im going on week 3 now after the shot.
I was incredibly sick, shaking, fainted, and in horrible pain everywhere. I had a massive sore on my arm snd a bog spot that lasted over two months.
LEFT BREAST HURTS, CHEST HURTS, BACK PAIN, SWELLING, PINKNESS
Narrative: Patient is on 80 y/o male who presented to ER on 12/6/21 with fatigue, right flank pain, and intermittent bloody stools after chemo for multiple myeloma for 1-2 weeks. PMH includes HTN, CHF, COPD, obesity, aortic stenosis, cardiomyopathy, and cardiac defibrillator. CT was consistent with diverticulitis probably early as well as confirmation of COVID-19 pneumonia. Admitted for further eval and treatment, also in the setting of immunosuppression. Treated with dexamethasone (12/6-12/14) and remdesivir (12/6-12/10). Discharged on 12/14 with supportive medications including albuterol, benzonatate, guaifenesin, and throat lozenges. To continue home oxygen.
Note: Resumption of interrupted Anthrax reactions seem to be reoccurring more frequently. Erythema, edema, pain, warmth to site, headache, malaise, body aches.
This report describes the occurrence of death in child of unspecified age who was vaccinated with hepatitis B vaccine recombinant (Engerix B) injection for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. On unspecified dates, the pt received a dose of Engerix-B (lot ENG 1944A and lot ENG1607A9). Los number ENG1944A is not a complete lot number for Engerix-B. On 12/10/2003, the pt's attorney alleged that "the thimerosal contained in the vaccines administered to the children (child) contributed to and/or caused their deaths." No further info regarding the specifics of the claim was available at this time. The cause of death is unknown at this time. It is unknown whether an autopsy was performed.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 18-SEP-2014 the patient was inadvertently vaccinated with a dose of PNEUMOVAX 23 (intramuscular, dose unknown) which expired on 21-FEB-2014. Pertinent medical history and concomitant medications were unspecified by reporter. No adverse effects reported. The outcome of the events was unknown. No further information was provided. Additional information has been requested.
The patient reports that with thin an hour or so of receiving both influenza and RSV vaccinations she developed a sensation of swelling in her mouth and face and generalized weakness.  It is unclear if the patient had a fever the symptoms lasted several days.  She reported local swelling at the RSV vaccination site and persistent fatigue that lasted a week.  She reported to me that she had previously tolerated influenza vaccination with out reaction.
Soreness in 75% of right side of body.  Reduced hearing in right ear.  Swelling at injection site.
Patient received the Moderna booster from this lot 045C21A 15 days after the lot was expired.  Patient was advised to return to the clinic for repeat booster as soon as possible.
This case was reported by a pharmacist via call center representative and described the occurrence of difficulty sleeping in a 60-year-old male patient who received SHINGRIX (batch number 5NY3B, expiry date 13th July 2020). On 30th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 30th May 2018, less than a day after receiving SHINGRIX, the patient experienced difficulty sleeping and anxiety. On 31st May 2018, the patient experienced movement disorder, tiredness, back pain, leg pain and weakness. On an unknown date, the outcome of the difficulty sleeping, back pain and leg pain were unknown and the outcome of the movement disorder, tiredness, anxiety and weakness were not recovered/not resolved. It was unknown if the reporter considered the difficulty sleeping, movement disorder, tiredness, anxiety and weakness to be related to SHINGRIX. The reporter considered the back pain and leg pain to be related to SHINGRIX. Additional details were provided as follows: The case was reported by the registered pharmacist. Less than a day after vaccination of SHINGRIX on left deltoid, the patient was anxious, had difficulty in sleeping. One day after vaccination, in the morning of the day of reporting, the patient was weak and tired and the patient called the pharmacist to report these issues along with his concern about back pain and pain in both legs, the patient also noted difficulty lifting one leg. She was encouraged to have him notify his physician and the prescribing information for stated adverse events was reviewed.
Sore arm for a few days; Left foot starting to feel numb/tingling; A spontaneous report was received from a consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm for a few days, left foot starting to feel numb tingling.  The patient's medical history was not provided. Concomitant medications reported were Claritin Allergies for drug use for unknown indication.  On 11 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) Sore arm for a few days, Left foot starting to feel numb tingling.  Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), sore arm for a few days, left foot starting to feel numb tingling was unknown.
Red, swollen arm day after Pneumovax administered.  Prednisone and Keflex prescribed.
Severe swelling/redness/soreness of arm from above elbow to below shoulder - increasing  to severe by 10th day after shot
Patient received vaccine 12/21/22; patient's sister reported to the pharmacy 12/29/22 that the patient was discovered deceased the morning of 12/29/22.  She said the patient had a slight cold the day he was given the vaccine and had local tenderness of his arm after vaccination.  She stated that the evening of 12/28/22 he complained of pain / stiffness in his whole body.  She stated that she believes the vaccine was responsible for patient's death.
Information has been received from a registered nurse (R.N.) concerning a 15 year old female who in 2008 (last year) was vaccinated with the first 0.5 mL dose of GARDASIL (Lot # was not provided). Patient experienced anxiety and not able to breathe after getting the first dose of GARDASIL. She did receive second and third dose but didn't experienced any AE. The patient sought unspecified medical attention and recovered from anxiety and not able to breathe. Additional information has been requested.
Left arm sore and swollen; Left arm sore and swollen; Headache; Fatigue; Sore muscles; Nausea; Fever; Chills; Cold sweats; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 23Apr2021 at 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 15:30, the patient experienced left arm sore and swollen, headache, fatigue, sore muscles, nausea, fever, chills and cold sweats. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm sore and swollen, headache, fatigue, sore muscles, nausea, fever, chills and cold sweats were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
the next day pt had body soreness all over, and 2 days after vaccine she developed hives all over her body